Breaking News
0

Novo Nordisk A/S Class B (NOVOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
327.7 +0.7    +0.21%
10:55:01 - Closed. Currency in DKK ( Disclaimer )
Type: Equity
Market: Denmark
ISIN: DK0060534915 
S/N: 1912564000
  • Prev. Close: 327.7
  • Open: 327.7
  • Day's Range: 326.8 - 329.7
Novo Nordisk B 327.7 +0.7 +0.21%

NOVOb Overview

 
Information about the Novo Nordisk A/S Class B Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close327.7
Day's Range326.8 - 329.7
Revenue111.83B
Open327.7
52 wk Range265.1 - 333.5
EPS15.74
Volume2,002,450
Market Cap784.51B
Dividend (Yield)8.15 (2.45%)
Average Vol. (3m)2,503,690
P/E Ratio19.32
Beta1.39
1-Year Change6.15%
Shares Outstanding2,394,000,000
Next Earnings DateMay 03, 2019
What is your sentiment on Novo Nordisk B?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S Class B News


Novo Nordisk A/S Class B Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Buy Buy Buy
Technical Indicators Strong Sell Sell Strong Sell Strong Buy Strong Buy
Summary Strong Sell Strong Sell Neutral Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Black Crows 15 Current
Gravestone Doji 1H Current
Harami Cross 1D Current
Completed Patterns
On Neck Bearish 15 1 Feb 20, 2019 10:30AM
Three Outside Up 1W 2 Feb 03, 2019
Falling Three Methods 5H 2 Feb 19, 2019 06:00AM

Novo Nordisk A/S Class B Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Real-time CFD 327.7 - - - +0.21% DKK 10:55:01  
  Copenhagen 327.10 0.00 0.00 2,002,450 +0.03% DKK 10:59:00  
  BATS Europe 327.9 0.0 0.0 582,826 +0.23% DKK 12:01:20  
  NYSE 49.78 0.00 0.00 524,970 -1.09% USD 12:00:30  
  London 328.50 0.00 0.00 88,592 -1.06% DKK 11:46:04  
  Mexico 955.080 0.000 0.000 2,400 -1.19% MXN 11:03:25  
  Switzerland 50.500 47.900 51.000 0 +0.00% CHF 18/02  
  Xetra 44.5000 44.2000 44.8000 0 +0.00% EUR 18/02  
  Dusseldorf 43.925 43.720 43.940 0 +0.02% EUR 09:36:00  
  Berlin 43.950 43.775 43.960 0 -0.81% EUR 02:01:00  
  Xetra 43.83 43.69 43.87 15,589 -0.40% EUR 11:35:00  
  Berlin 44.300 43.800 43.900 0 -0.23% EUR 02:08:00  
  Stuttgart 43.935 43.715 43.840 2,099 -0.39% EUR 10:31:00  
  Munich 44.105 43.725 43.935 255 +0.67% EUR 03:29:00  
  Frankfurt 43.93 43.73 43.94 3,124 -1.13% EUR 09:55:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 172.71 173.32 171.00 +1.74 +1.02% 12.56M 12:01:38  
  Tesla 302.22 306.30 301.46 -3.42 -1.12% 3.61M 12:01:29  
  Netflix 361.07 366.71 360.53 -0.80 -0.22% 3.56M 12:01:40  
  Alphabet A 1,130.75 1,130.60 1,125.00 +4.02 +0.36% 322.43K 12:01:39  
  Facebook 162.84 163.72 161.89 +0.55 +0.34% 4.20M 12:01:38  
  Amazon.com 1,630.61 1,634.93 1,624.00 +3.00 +0.18% 1.23M 12:01:05  
  Arts-Way 2.230 2.490 2.190 -0.270 -10.80% 374.52K 12:01:12  
  CVS Health Corp 64.93 65.13 63.30 -4.94 -7.06% 29.10M 12:01:38  
  Alibaba 172.48 172.68 170.87 +2.32 +1.36% 6.09M 12:01:41  
  NVIDIA 160.07 161.26 157.40 +3.42 +2.18% 7.04M 12:01:38  

Novo Nordisk A/S Class B Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

43161

Equity Type

ORD

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jorgen Andersen
Jorgen Andersen Feb 06, 2019 4:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone got a view on how much the Trump/US plans to reduce medical prices will affect the share price?
Reply
0 0
Manbear Pig
Manbear Pig Feb 17, 2017 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Extremely bullish double bottom pattern and fibbonacci retracement with convergence of relative strenght index upwards
Reply
1 0
Juan Francisco Olmos
Juan Francisco Olmos Mar 31, 2014 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
Reply
0 0
Juan Francisco Olmos
Juan Francisco Olmos Mar 31, 2014 4:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email